Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · Real-Time Price · USD
2.920
-0.120 (-3.95%)
At close: Nov 20, 2024, 4:00 PM
2.870
-0.050 (-1.71%)
Pre-market: Nov 21, 2024, 5:50 AM EST

SONN Stock Forecast

SONN's stock price has decreased by -74.65% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for SONN stock have an average target of 117.33, with a low estimate of 56 and a high estimate of 240. The average target predicts an increase of 3,918.15% from the current stock price of 2.92.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $56 $117.33 $56 $240
Change +1817.8% +3918.2% +1817.8% +8119.2%
* Price targets were last updated on Aug 23, 2024.

Analyst Ratings

The average analyst rating for SONN stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 443333
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 443333

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$240
Strong Buy Maintains $240 +8,119.18% Aug 23, 2024
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$240
Strong Buy Maintains $240 +8,119.18% May 28, 2024
EF Hutton
EF Hutton
Strong Buy
Maintains
$88$56
Strong Buy Maintains $88$56 +1,817.81% May 16, 2024
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$600$240
Strong Buy Maintains $600$240 +8,119.18% Feb 15, 2024
Ladenburg Thalmann
Ladenburg Thalmann
Strong Buy
Initiates
$56
Strong Buy Initiates $56 +1,817.81% Nov 27, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
38.25K
from 147.81K
Decreased by -74.12%
Revenue Next Year
n/a
from 38.25K
EPS This Year
-13.10
from -145.12
EPS Next Year
-15.26
from -13.10
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Sep 30, 2019 Sep 30, 2020 Sep 30, 2021 Sep 30, 2022 Sep 30, 2023 Sep 30, 2024 Sep 30, 2025
Revenue
--483.63K349.94K147.81K38.25K-
Revenue Growth
----27.64%-57.76%-74.12%-
EPS
----1,204.14-145.12-13.10-15.26
EPS Growth
-------
Forward PE
-------
No. Analysts -----43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 78,750 n/a
Avg 38,250 n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20242025
High
-46.7%
-
Avg
-74.1%
-
Low - -

EPS Forecast

EPS 20242025
High -13.44 -15.71
Avg -13.10 -15.26
Low -12.62 -14.66

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.